Increased Tau Phosphorylation and Impaired Presynaptic Function in Hypertriglyceridemic ApoB-100 Transgenic Mice

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Lénárt, Nikolett ^a   Szegedi, Viktor ^b   Juhász, Gábor ^b   Kasztner, Aniko ^a   Horváth, János ^c   Bereczki, Erika ^a,d   Tóth, Melinda E ^a   Penke, Botond ^b,c   Sántha, Miklós ^a  

^a INSTITUTE OF BIOCHEMISTRY   (Hungary)

^b BAY ZOLTÁN NONPROFIT LTD FOR APPLIED RESEARCH   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEIN KINASE C GAMMA; SERINE; TAU PROTEIN; TRIACYLGLYCEROL;

AGE DISTRIBUTION; AGED; AGING; AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; HIPPOCAMPUS; HYPERTRIGLYCERIDEMIA; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; LONG TERM POTENTIATION; MOUSE; NERVE CELL PLASTICITY; NERVE DEGENERATION; NONHUMAN; PRESYNAPTIC POTENTIAL; PROTEIN PHOSPHORYLATION; TRIACYLGLYCEROL BLOOD LEVEL;

AGING; ANIMALS; APOLIPOPROTEIN B-100; APOPTOSIS; BRAIN; ELECTROPHYSIOLOGICAL PHENOMENA; HUMANS; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONAL PLASTICITY; NEURONS; PHOSPHORYLATION; PLAQUE, AMYLOID; TAU PROTEINS; TRIGLYCERIDES;

ANIMALIA; MUS MUSCULUS;

EID: 84866645920     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046007     Document Type: Article

References (40)

1. Panza F, D'Introno A, Colacicco AM, Capurso C, Pichichero G, et al. (2006) Lipid metabolism in cognitive decline and dementia. Brain Res Rev 51: 275-292.
2. Watanabe T, Koba S, Kawamura M, Itokawa M, Idei T, et al. (2004) Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia. Metabolism 53: 476-482.
3. Cromwell WC, Barringer TA, (2009) Low-density lipoprotein and apolipoprotein B: clinical use in patients with coronary heart disease. Curr Cardiol Rep 11: 468-475.
4. Süle Z, Mracskó E, Bereczki E, Sántha M, Csont T, et al. (2009) Capillary injury in the ischemic brain of hyperlipidemic, apolipoprotein B-100 transgenic mice. Life Sci 84: 935-939.
5. Martins IJ, Berger T, Sharman MJ, Verdile G, Fuller SJ, et al. (2009) Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease. J Neurochem 111: 1275-1308.
6. Caramelli P, Nitrini R, Maranhão R, Lourenço AC, Damasceno MC, et al. (1999) Increased apolipoprotein B serum concentration in Alzheimer's disease. Acta Neurol Scand 100: 61-63.
7. Sabbagh M, Zahiri HR, Ceimo J, Cooper K, Gaul W, et al. (2004) Is there a characteristic lipid profile in Alzheimer's disease? Alzheimer's Dis 6: 585-589.
8. Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santamato A, et al. (2010) Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev 9: 399-417.
9. Selkoe DJ, (1996) Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 271: 18295-18298.
10. Hardy J, Selkoe DJ, (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356.
11. Spillantini MG, Goedert M, (1998) Tau protein pathology in neurodegenerative diseases. Trends Neurosci 21: 428-433.
12. Pei JJ, Sjögren M, Winblad B, (2008) Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets. Curr Opin Psychiatry 2: 555-561.
13. Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, et al. (2008) Abeta- degrading enzymes in Alzheimer's disease. Brain Pathol 18: 240-252.
14. Rodríguez JJ, Olabarria M, Chvatal A, Verkhratsky A, (2009) Astroglia in dementia and Alzheimer's disease. Cell Death Differ 16: 378-385.
15. Zlokovic BV, (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57: 178-201.
16. Bjelik A, Bereczki E, Gonda S, Juhász A, Rimanóczy A, et al. (2006) Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis. Neurochem Int 49: 393-400.
17. Csont T, Bereczki E, Bencsik P, Fodor G, Görbe A, et al. (2007) Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice. Cardiovascular Res 76: 100-109.
18. Yanagisawa M, Planel E, Ishiguro K, Fujita SC, (1999) Starvation induces tau hyperphosphorylation in mouse brain: implications for Alzheimer's disease. FEBS Lett 461: 329-333.
19. Greenspan P, Mayer PE, Fowler DS, (1985) Nile red: a selective fluorescent stain for intracellular lipid droplets. J Cell Biol 100: 965-973.
20. Fowler SD, Greeanspan P, (1985) Application of Nile Red, a fluorescent hydrophobic probe, for the detection of neutral lipid deposits in tissue sections: Comparison with Oil red O. J Histochem Cytochem 33: 833-836.
21. Pelech S, Sutter C, Zhang H, (2003) Kinetworks™ protein kinase multiblot analysis. Methods in Molecular Biology: Cancer Cell Signaling: Methods and Protocols (Terrian, D.M, ed.). Humana Press 218: 99-111.
22. Schmued LC, Stowers CC, Scallet AC, Xu L, (2005) Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res 1035: 24-31.
23. Su Q, Tsai J, Xu E, Qiu W, Bereczki E, et al. (2009) Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance. Hepatology 50: 77-84.
24. Takeuchi A, Irizarry MC, Duff K, Saido TC, Hsiao Ashe K, et al. (2000) Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am J Pathol 157: 331-339.
25. Callow MJ, Stoltzfus LJ, Lawn RM, Rubin EM, (1994) Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice. Proc Natl Acad Sci USA 91: 2130-2134.
26. Antonios N, Angiolillo DJ, Silliman S, (2008) Hypertriglyceridemia and ischemic stroke. Eur Neurol 60: 269-278.
27. Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, et al. (2012) ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models. Science 335: 1503-1506.
28. Sparks DL, Liu H, Gross DR, Scheff SW, (1995) Increased density of cortical apolipoprotein E immunoreactive neurons in rabbit brain after dietary administration of cholesterol. Neurosci Lett 187: 142-144.
29. Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, et al. (2008) ApoE promotes the proteolytic degradation of Abeta. Neuron 58: 681-693.
30. Wang JZ, Grundke-Iqbal I, Iqbal K, (2007) Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci 25: 59-68.
31. Sengupta A, Kabat J, Novak M, Wu Q, Grundke-Iqbal I, et al. (1998) Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. Arch Biochem Biophys 357: 299-309.
32. Maas T, Eidenmüller J, Brandt R, (2000) Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. J Biol Chem 275: 15733-15740.
33. Wang D, Yuen EY, Zhou Y, Yan Z, Xiang YK, (2011) Amyloid beta peptide-(1-42) induces internalization and degradation of beta2 adrenergic receptors in prefrontal cortical neurons. J Biol Chem 286: 31852-31863.
34. Chui DH, Tanahashi H, Ozawa K, Ikeda S, Checler F, et al. (1999) Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat Med 5: 560-564.
35. Chen Q, Nakajima A, Choi SH, Xiong X, Tang YP, (2008) Loss of presenilin function causes Alzheimer's disease-like neurodegeneration in the mouse. J Neurosci Res 86: 1615-1625.
36. Chan A, Shea TB, (2006) Dietary and genetically-induced oxidative stress alter tau phosphorylation: influence of folate and apolipoprotein E deficiency. J Alzheimer's Dis 9: 399-405.
37. Farr SA, Yamada KA, Butterfield DA, Abdul HM, Xu L, et al. (2008) Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology 149: 2628-2636.
38. Saito N, Shirai Y, (2002) Protein kinase C gamma (PKC gamma): function of neuron specific isotype. J Biochem 132: 683-687.
39. Abeliovich A, Chen C, Goda Y, Silva AJ, Stevens CF, et al. (1993) Modified hippocampal long-term potentiation in PKC gamma-mutant mice. Cell 75: 1253-62.
40. Abeliovich A, Paylor R, Chen C, Kim JJ, Wehner JM, et al. (1993) PKC gamma mutant mice exhibit mild deficits in spatial and contextual learning. Cell 75: 1263-71.